U dergo progressive restriction of lineage potential and acquire the characteristics of mature, terminally differentiated cells is central to developmental biology. Hematopoietic stem cells and differentiated progenitors are among the best studied and have contributed an important model system for cell differentiation. In this context, hematopoiesis is the process by which blood cells acquire defining phenotypes as a result of coordinated, cell-specific gene expression. The pattern of gene expression within a cell is established by cell-specific transcription factors that mediate the net effect of the variety of proliferation and differentiation signals which impinge on it. Hence, an understanding of transcription factor function is essential to the study of differentiation.
One convenient way to coordinate the expression of many individual genes in a terminally differentiated cell is through the aegis of one or a few cell-specific transcription factors. In this simplified scenario, pivotal steps in differentiation are linked to the activation of key transcriptional regulators. The processes actually governing cell differentiation are undoubtedly more complex and are probably mediated through combinations between cell-specific and widely expressed proteins. Nevertheless, lineage-restricted transcription factors provide a valuable starting point in probing the molecular mechanisms of cell differentiation. Studies in this area have been greatly facilitated by advances in mouse genetic techniques, and the results and hypotheses generated by selected experiments involving hematopoietic transcription factors will be reviewed here. Our purpose is to describe representative murine studies that illustrate emerging concepts and to outline outstanding questions.
KNOCKOUT MICE: KEYS TO GENETIC ANALYSIS
Naturally occumng mutations have been a rich source of insight into normal gene function, particularly in the case of hematopoietic genes. Similarly, the study of fundamental developmental processes has relied heavily on induced mutations in invertebrates and lower vertebrates, particularly Caenorhabditis elegans and Drosophila. However, naturally occumng mutations highlight only a fraction of genes and, until recently, investigators were limited in their ability to study the effects of induced mutations in vivo in the context of an otherwise intact mammal. The development of transgenesis in the mouse in the early 1980s provided an opportunity to manipulate the genetic make-up of a higher vertebrate. Subsequent to this, the introduction of technology whereby mutations can be engineered into any gene in the mouse (Fig 1) '-3 has revolutionized the genetic analysis of cellular processes, particularly in the area of differentiation and embryonic development.
Gene knockout experiments are based on the use of murine embryonal stem (ES) cells, which are derived from the inner cell mass of the 32-cell stage preimplantation blastocyst and can be maintained in a totipotential state in culture. Upon reintroduction into a host blastocyst, they contribute to all tissues of a chimeric mouse, including germ cells. Accordingly, a mutation engineered in ES cells in tissue culture is introduced into the gennline of the mouse. Breeding of chimeras results in transmission of the mutation, initially into heterozygote mice, which can be mated to homozygosity for an autosomal locus (Fig 2) . Another invaluable property of ES cells is their capacity to differentiate in vitro under appropriate culture conditions, particularly into hematopoietic precursors4-'; this permits the consequences of mutation of specific genes in ES cells to be examined in vitro.
DEVELOPMENTAL HEMATOPOIESIS: DEFINITION OF TERMS
Hematopoiesis in vertebrates occurs in distinct phases and anatomic sites during development.*-" Primitive, or embryonic, hematopoiesis represents a transient wave that begins when blood develops from the mesoderm of the yolk sac, around embryonic day 7.5 (E7.5) in mice or day 15 to 18 in humans. Erythrocytes produced at this time synthesize embryonic globin chains (C,,tIPHl) and remain nucleated. Definitive hematopoiesis is initiated in the fetal liver around El 1 in the mouse (day 35 to 42 in humans) and is characterized by the production of non-nucleated erythrocytes that express fetal globins (cr,y) in humans but adult globin genes Although key differentiation events are mediated by a panoply of transcriptional activators, one family of proteins plays a pivotal role in several cell types. Cell fate determination in myogenic" and lineages and sex determination in Drosophila'" are critically dependent on transcription factors bearing the basic helix-loop-helix (bHLH) motif." This motif is shared among a variety of cell-specific (eg, MyoD and Mash-1 ) as well as widely expressed (eg. cmyc and E2A gene products) transcription factors and mediates gene regulation by virtue of binding cis elements with the sequence CANNTG (E boxes)." bHLH factors expressed in hematopoietic cells have been identified through cloning of chromosomal translocation breakpoints associated with human acute T-cell leukemia and include tal-I (SCL). tal-?.
Among the hematopoietic bHLH factors. tal-I/SCL has been of particular interest for several reasons. First. one of the leukemic clones in which it was originally identified showed the potential to differentiate along both myeloid and lymphoid lineages, ostensibly a "stem cell" attribute.".24 Second. expression of the gene is evident among early hematopoietic progenitor^,".^^ although it is also detected in more mature erythroid cells, mast cells, megakaryocytes, and endothelial cells. In Xenopu.y embryos. tal-l/SCL expression precedes that of other known hematopoietic genes in the earliest sites of blood formation (P. Hahn et al. unpublished data). A role for tal-I/SCL in late erythroid differentiation has also been suggested.'"
Mice homozygous for deletion of the tal-I/SCL gene die in utero as a result of the absence of blood formation'".'': no blood cells are detected within the yolk sac or embryo proper. which are consequently pale and growth-retarded (Fig 3A) . However. there is no obvious effect on organogenesis or on mesodermal differentiation along nonhematopoietic paths. RBCs represent the only hematopoietic requirement for survival of an embryo. so the status of other blood lineages has been determined using in vitro colony assays. These studies show additional failure of myelopoiesis and thus implicate tal-l/SCL in a critical function very early during hematopoietic differentiation. Possibilities include determination of blood cell fate and development (or maintenance) of immature multipotential hematopoietic progeni tors. For personal use only. on November 11, 2017. by guest www.bloodjournal.org From or effects on late erythroid maturation and lymphopoiesis. One approach to this deficiency is through analysis of differentiation of homozygous mutant (null) ES cells in vitro. Accordingly, we have recently shown that tal-1/SCL-null ES cells fail to produce all hematopoietic lineages as a specific consequence of the knockout?' In this and other cases, complementation of the lymphoid defect in RAG 2-deficient mice has proved to be a powerful method for assessing the role of a gene product specifically in lymphoid cell development and function.33 Alternative approaches involve engineering the targeted mutation in such a fashion that it is manifested only after the completion of embryonic development or exclusively in selected t i s s~e s .~~-~~ Some of the latter techniques use the site-specific Cre recombinase and are particularly likely to find broad application in the study of hematopoiesis.
Second, the apparently complete absence of hematopoietic cells in tal-1/SCL-null embryos at the time of death precludes extensive study of the nature of the developmental block. We have hypothesized, based on the above data and on the analogous role of related bHLH factors in myogenesis and neurogenesis, that tal-1/SCL functions in the initial differentiation of blood from mesoderm. However, the molecular basis of tal-1/SCL function, and its position relative to other nuclear proteins (such as GATA factors, the E2A gene products, and Rbtn2) in a hierarchy of transcriptional regulation, can only be addressed in combination with other experimental approaches.
Third, the above findings indicate that tal-l/SCL is not required for the formation of endothelial cells or blood vessels, although it is expressed in these Several explanations may account for this result. One possibility is that tal-1/SCL plays no role in these processes and that endothelial expression of this transcription factor is either irrelevant or required for aspects of endothelial cell function that are not readily apparent. Alternatively, other transcription factors with overlapping function may compensate for absence of tal-1/SCL in vascular but not in hematopoietic cells. This possibility does not preclude a primary role for a given factor in vivo; rather, it provides for assumption of critical functions by other molecules under the experimental circumstance of targeted deficiency. However, it is probably naive to always ascribe the absence of a phenotype in knockout mice to functional redundancy. Highly conserved genes are unlikely to have survived selective pressures in the face of widespread functional overlap and absence of a phenotype probably frequently reflects the inability to detect one. Certainly, there are several examples of effects observed only when knockout mice are appropriately ~t r e s s e d ,~~.~' a situation that is arguably more relevant when gene function is considered in an evolutionary context. Finally, it is important to bear in mind that mutant phenotypes are likely to be influenced to various degrees by the genetic background upon which they are observed. Examples outside the hematopoietic system call for due caution in interpreting the results of gene knockouts in a single mouse ~train. 4 
'~~

A DIFFERENTIATION ARREST PHENOCOPY THE CASE OF rbtn2/LMO2
The Lim-domain nuclear protein rbtn2/Ttg2/LM02 has important connections with tal-l/SCL. The genes encoding each of these proteins may be dysregulated in human T-cell acute lymphoblastic leukemia (ALL).23""5 Although rbtn21 LM02 is expressed in a wider variety of cells, message levels are highest in hematopoietic tissues, including fetal liver4; neither gene is normally expressed in T lymphocytes. Remarkably, although tal-1/SCL forms heterodimers with the ubiquitous products of the E2A gene both in vitro and in viv0,4~,~* more than half of the immunoprecipitable rbtn2/ LM02 protein in erythroid cells exists in a complex with tal-1/SCL?9*50 Sequence-specific DNA binding has not been shown for rbtn2LM02; thus, modulation of gene transcription through protein-protein interactions" seems plausible.
Mice lacking rbtn2LM02 function resemble the bloodless mice lacking tal-1/SCL and die in utero at approximately the same age46; erythrocytes are missing and anemia is presumed to be the cause of death. In colony assays on yolk sac tissue, myeloid cell development was initially reported to be ~naffected~~; however, further studies indicate that this is not the case (A. Warren and T. Rabbitts, personal communication). Thus, tal-1/SCL and rbtn2LM02 are both required at a very early stage in hematopoiesis.
The similarity between the tal-1/SCL and rbtn2LM02 knockout phenotypes suggests that the physical interaction between these proteins is physiologic and that they function in a common pathway of gene regulation. Together, these factors might control or establish a primitive genetic program, perhaps one that favors cell growth in a relatively undifferentiated state. The relevant target genes during normal hematopoiesis or in leukemic cells remain unknown but may represent overlapping subsets, and their identification remains an important challenge.
A BLOCK IN ERYTHROPOIESIS: THE CASE OF GATA-1
The DNA sequence motif GATA is present in important &-regulatory elements of many erythroid-expressed genes. The zinc finger protein GATA-1,52,53 which binds this sequence, thus poses as an excellent candidate for a central regulator of erythroid-specific gene expression and differentiation. Within hematopoietic cells, expression of GATA-1 is limited to the erythroid, megakaryocyte, eosinophil, and mast cell lineages and multipotential progenitor^.^^-^^ Targeted disruption of the mouse GATA-1 gene has provided strong evidence for its role as a key regulator of erythroid differentiation. When injected into host blastocysts, GATA-1 -negative ES cells fail to contribute to mature RBCs but are fully able to develop into other hematopoietic lineages as well as other
The consequences of absence of GATA-1 have been further defined by in vitro differentiation assays,59360 which show a maturation arrest of erythroid precursors at the proerythroblast stage (Fig 4A) , followed by apoptosis of these cells.61 Thus, although a role for GATA-binding factors in lineage selection is possible, as discussed below, it is survival and terminal maturation of erythroid precursors that appear to be critically dependent on GATA-1.
GATA-1: CONCENTRATION-DEPENDENT REGULATOR OF CELL LINEAGE?
One might anticipate a putative lineage-determining factor to induce differentiation along a particular pathway when For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
expressed or activated within a naive or heterologous cell. A paradigm is provided by the myogenic bHLH factors, which can convert multiple cell types into m u s~l e . 6~*~~ Lineage determination of this type by hematopoietic transcription factors has been more difficult to demonstrate, in part because of the paucity of appropriate undifferentiated cell lines. Nonetheless, forced expression of GATA-1 in the multipotential cell line 416B promotes megakaryocytic differentiati~n,"~~ whereas forced expression in retrovirally transformed chicken myeloblasts promotes differentiation of thromboblasts, eosinophils, and erythroblasts at the expense of myelomonocytic lineages.% Remarkably, the latter effect may depend in part on the intracellular levels of GATA-I. Cell lines with the highest concentration exhibit megakaryocytic features, whereas those with approximately fourfold For personal use only. on November 11, 2017. by guest www.bloodjournal.org From lower levels display properties of eosinophils. Such an effect, which has not been reported in the case of myogenic bHLH factors, emphasizes the complexity underlying the transcriptional basis of lineage determination. Furthermore, GATA-I. perhaps similarly to tal-I/SCL,"' may function in both lineage selection and late erythroid maturation, presumably acting through distinct target genes.
Together with the derivation of erythroid and megakaryocytic cells from a common p r e~u r s o r "~.~~ and expression of GATA-1 in these experiments suggest that it may play a role in differentiation of multiple blood lineages. However, in vitro differentiation and chimera analyses indicate that megakaryocytes and mast cells can form in the absence of GATA-1 Although future studies may show subtle functional effects related to altered gene expression in these cells, clearly sites of transcription factor expression are not uniformly indicative of critical functions related to differentiation.
OTHER PATHS TO BLOODLESSNESS . . . ALMOST THE CASE OF GATA-2 GATA-I belongs to a small family of related zinc-finger transcription factors with different expression patterns and, presumably, distinct target geneshq Hematopoietic expression of GATA-2 overlaps with that of GATA-I, although it is also expressed more widely, including in undifferentiated ES cells7" and endothelial cells.7' In contrast, GATA-3 expression is widespread during embryogenesis but restricted to T lymphocytes and the nervous system in adults.72
Three aspects of GATA-2 expression and function are intriguing. First, its expression is detected in erythroid and other hematopoietic progenitors and decreases as GATA-1 expression increases with erythroid differentiati~n.~' Second, in chicken erythroid precursors, forced expression of GATA-2. but not of GATA-I or GATA-3, promotes proliferation and blocks differentiati~n.~' Finally, in erythroid cells cultured from GATA-I-null ES cells, GATA-2 is expressed at 50-fold greater levels than in control cells, presumably due to the absence of normal downregulation from the high levels present in progenitors.'" Together, these findings suggest that GATA-2 may serve specific functions in early hematopoietic cell development and proliferation.
Mice lacking GATA-2 exhibit a severe and early hematopoietic defect. They survive to E 10-I I , but succumb to anemia due to a marked reduction in the number of embryonic RBCs7' (Fig 3B) . Results from in vitro differentiation of GATA-2-null ES cells parallel the in vivo findings, showing up to a 100-fold decrease in the frequency of primitive erythroid colonies and even greater reduction in the appearance of definitive erythroid and mast cell colonies. Furthermore, only a minimal contribution of GATA-2-null cells to the lymphoid compartment can be detected in the RAG-2-'-blastocyst complementation assay." Thus, absence of GATA-2 results in a hematopoietic defect that is broader than that observed in the absence of GATA-I; all hematopoietic lineages are profoundly affected. Loss of GATA-2 has no apparent effect on endothelial cells.
These results refine the proposed role for GATA-2 in hematopoiesis by suggesting that the factor is essential for appropriate expansion of early hematopoietic cells; in contrast, differentiation along specific hematopoietic lineages is not obviously impaired in its ab~ence.~.' One specific possibility suggested, but not proved, by the data is that GATA-2 mediates responsiveness to growth factors, particularly the c-kit ligand. Indeed, defects in the c-kit signaling pathway, shown in part through SI and W mice, are also more prominent in definitive than in primitive hematop~iesis.~'.~" Although the data do not presently permit a clear distinction between effects manifested at the level of the stem cell or of multipotential progenitors, they indicate a requirement for GATA-2 early in the program of hematopoiesis.
Mice lacking the related factor GATA-3 also display hematopoietic abnormalities, including lethal embryonic hemorrhage. despite the presence of megakaryocytes, and defecFor personal use only. on November 11, 2017. by guest www.bloodjournal.org From tive fetal liver h e m a t o p~i e s i s .~~ Whether these hematologic disturbances are primary or secondary, and the effect of GATA-3 loss on T-cell development, have not been reported.
PRIMITIVE BUT NOT DEFINITIVE: THE CASE OF C-Myb AND AML-1
Expression of c-myb, the cellular homolog of the v-myb nuclear oncoprotein, is abundant within immature hematopoietic cells of all lineages and decreases as these cells differentiate.7x-x" In vitro, forced expression of c-myb inhibits erythroid differentiation,R' whereas antisense c-myb oligonucleotides lead to growth arrest and inhibition of hematopoietic colony formation.*' The E26 virus, which contains both v-myb and v-ets, induces leukemias of erythroid and myeloid lineage~,R~.'~ and transformation of macrophages by v-myb produces immature myeloblasts.x5 Although c-myb is also expressed in cells of the nervous system and gut, its function outside hematopoietic cells has not been examined extensively.
Mice lacking c-myb function display a remarkable phenotype. Yolk sac (primitive) hematopoiesis progresses normally, leading to normal early development, including organogenesis, whereas fetal liver (definitive) hematopoiesis is severely impaired86; animals die in utero by E15 (Fig 3C) . The number of mature circulating definitive erythrocytes and of progenitors of other hematopoietic lineages is decreased approximately IO-fold compared with normal littermates, although megakaryocyte numbers and morphology are curiously unaffected. Granulocytes and monocytes appear to be normal, suggesting a quantitative rather than a qualitative differentiation defect.
This phenotype has been interpreted to reflect a proliferation abnormality of definitive hematopoietic stem cells or of multipotential progenitors within the fetal liver microenvironment86 and is reminiscent of the effect of the absence of GATA-2 on yolk sac hematopoie~is.~' However, the presence of megakaryocytes might argue against this simple hypothesis and raises the possibility that individual committed hematopoietic progenitors, with the exception of megakaryoblasts, are separately affected by the absence of c-myb. The ability of c-myb mutant yolk sacs to generate myeloid colonies in vitro or of mutant ES cells to undergo lymphoid development has not been reported. However, transgenic mice expressing a dominant interfering myb gene in T lymphocytes show impairments in thymopoiesis and T-cell proliferation."
The gene locus encoding AML-1, the runt-related LY subunit of the heterodimeric transcription factor core-binding factor (CBF), is a frequent target of rearrangement in acute myelogenous leukemia (AML) and childhood ALL.45 88 This gene is normally expressed in myeloid and lymphoid cells, within which potential target genes include interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and T-cell antigen and monocyte colony-stimulating factor (M-CSF) receptors. The preliminary analysis of AML-1 knockout mices9 suggests a block in development of all definitive hematopoietic lineages, including megakaryocytes, leading to fetal death by E12.5; primitive hematopoiesis is thus not affected. Hemorrhage appears to contribute to this fetal wastage, raising the possibility of an additional, perhaps vascular, defect. It will be interesting to determine whether this phenotype largely reflects absence of multiple cytokines and cytokine receptors; such evidence would provide a notable example of the relationship between a critical transcription factor and those target genes that are most relevant for normal differentiation.
The above findings support the notion that primitive and definitive hematopoiesis are controlled by distinct genetic programs and likely differ in fundamental ways other than anatomic location and response to growth factors. Unfortunately, these data do not allow one to conclude whether the disparate genetic programs operate on common or distinct hematopoietic stem cells, which remains a central question in developmental hematology. Nevertheless, they establish c-myb and AML-1 as pivotal regulators of definitive hematopoiesis.
THE CASE OF PU.l
The transcription factor PU. 1, the product of the Spi-I / Sfpi 1 P U . I protooncogene, is a hematopoietic-specific member of the ets fa mil^^'.^' expressed principally in monocytes/ macrophages and B lymphocytes, but also in erythroid cells and granulocytes. Potential target genes have been identified in myeloid and B cells, including the Ig h light chain and the integrin CD11b92-94; a role for the factor in P-globin gene expression and erythroid differentiation has also been p r o p~s e d .~' ,~~ PU.1 is more important for myeloid than for erythroid differentiation of human CD34' progenitors in vitro."
Mice lacking PU.l function die 1 to 3 days before their expected birth.9x The principal hematopoietic defects are absence of monocytes, granulocytes, and T and B lymphocytes, as measured by flow cytometry, histochemistry, in vitro colony assays, and diagnostic Ig and T-cell receptor gene rearrangements. The basis for their highly variable anemia is unclear (erythroid precursors are present and P-globin gene expression is unaffected), and it is not an obvious cause for the uniform preterm mortality. In a separate PU.1 knockout, the mutant animals can remain viable for up to a few days after birth, and T-cell development appears not to be affected (S. McKercher and R. Maki, unpublished data). Nevertheless, the absence of PU.1 results in apparent ablation of at least those mature hematopoietic lineages in which the gene is normally expressed (monocytes, neutrophils, and B lymphocytes).
It remains unclear whether these observations reflect defects in single or multiple distinct progenitors and whet the ontogenic relationship is between the affected lineages. One possibility is that there is a critical requirement for PU. 1 either in lineage commitment or in maturation of a common myelo-lymphoid progenitor.'x However, the existence of such a cell is controversial; a more likely possibility is an independent effect in several distinct precursor cells. As with the c-myb knockout, a distinction between these possibilities is critical for a fuller understanding of the specific requirements for individual transcription factors in hematopoietic differentiation.
The function of adjacent cis-elements within the Ig h and K 3' enhancers requires binding by two mutually dependent For personal use only. on November 11, 2017. by guest www.bloodjournal.org From transcription factors, one of which is PU.1; the other has been designated NF-EM5.93,99 Although interaction between myb and NF-M (the chicken homologue of CIEBPP) is required for myeloid expression of the mim-1 gene," a similarly strict requirement, reflecting cooperation between proteins with distinct expression patterns, has yet to be reported for PU.1 in myeloid promoters. The recent cloning of the lymphoid-specific NF-EMSPip gene''' will permit determination of its role in myelo-lymphopoiesis.
Although the PU. 1-related transcription factor Ets-1 is required for aspects of lymphocyte h o m e o s t a~i s ,~~~.~~~ its role in other lineages has not been reported. The essential roles, if any, of other ets family transcription factors in hematopoietic differentiation also remain to be established.
SPECIFICITY VIA SELECTIVE TARGETS: THE CASE OF EKLF
The CACCC nucleotide sequence is one of the cis-regulatory motifs critical for transcription of erythroid-expressed genes, including globins.IM As with other regulatory elements, an understanding of transcriptional activation mediated through this motif has been complicated by the multiplicity of proteins binding to it. Both erythroid-specific and ubiquitously expressed nuclear factors recognize the CACCC motif, and the contribution of the individual proteins to regulated gene expression remains an important question. Differential screening of an erythroleukemia cDNA library showed an erythroid-specific CACCC-binding protein, designated erythroid Kruppel-like factor (EKLF),Io5 which is expressed at all stages of erythropoiesis in the developing mouse. In vitro, EKLF binds preferentially to the CACCC site found in the @-globin promoter relative to similar sites present in promoters of embryonic or fetal globin genes.Io6 Moreover, the protein activates /?-globin promoter constructs through the normal CACCC site but fails to bind or activate promoters carrying mutations of the site that are seen in some patients with P-thalassemia.
Mice lacking EKLF die in utero at the fetal liver stage with a thalassemia syndrome (Fig 3D) because of inefficient pglobin Yolk sac erythropoiesis is unimpaired, and other genes whose promoters contain CACCC sites, including GATA-1, porphobilinogen deaminase, erythropoietin receptor, and carbonic anhydrase-1, are expressed at or near normal levels. Thus, in vivo EKLF is dispensable for erythroid commitment, primitive hematopoiesis, proliferation of erythroid precursors, or expression of most erythroid genes. Rather, this factor appears to be required principally for the expression of P-globin and perhaps a limited repertoire of other, as yet unidentified, target genes in erythroid cells.
Although the effects of absence of the other transcription factors discussed in this review could in principle result from the consequent absence of a single target gene product, it is more likely that in most instances a broader program of gene expression is affected. In this regard, EKLF is fundamentally different in that it appears to be a factor required for the regulation of few genes. The phenotype of EKLF knockout mice raises additional interesting questions. Because EKLF transcripts can be detected early in hematopoiesis, before adult P-globin expression, is there a subtle role for this factor in yolk sac hematopoiesis? Because other CACCC-binding factors are widely expressed, which of them function(s) in regulating erythroid-expressed genes, and how is erythroid specificity determined in these cases? Gene targeting is only one of several approaches toward addressing these questions.
UNEXPECTED INSIGHTS INTO THROMBOPOIESIS: THE CASE OF NF-E2
As illustrated above, analysis of transcriptional regulators that interact with cis-elements located within a-and ,&globin locus control regions (LCRs) has been a rich source of insight into erythroid differentiation. lw Besides GATA and CACCC sequences, a third motif present within these regions is related to sequences that bind the AP-1 family of regulatory proteins and has been designated NF-E2."' Studies in cultured erythroleukemia cells and in transgenic mice have consistently suggested that cell-specific enhancement of globin gene expression is mediated in large part through this DNA motif."""' The transcription factor NF-E2, which functions at this site, is a heterodimer comprised of hematopoietic-specific (p45) and widely expressed (p18) subunits, both of which belong to the basic region-leucine zipper (bZip) family of nuclear protein^."^."^ Expression of p45 NF-E2 is restricted to erythroid and mast cells, megakaryocytes, and multipotential hematopoietic progenitor^.'^."^ Mice lacking p45 NF-E2 develop normally in utero; however, the vast majority die within the first week of life ( Fig  3E) . Remarkably, erythroid cell development per se is only subtly affected in that rare surviving animals show a mild hypochromic anemia'I5; death results from a hemorrhagic diathesis caused by the absence of circulating platelets."6 Megakaryocytes are present but show profound cytoplasmic abnormalities, including a dramatic reduction in granule numbers, disorganized demarcation membranes, and a failure to delimit platelet territories (Fig 4C) . Molecular and cellular studies show a differentiation arrest that occurs relatively late in megakaryocyte maturation and does not directly involve signaling by thrombopoietin. Thus, NF-E2, which is known to be present in megakaryocytes, is essential within this lineage for regulated expression of genes that are required for cytoplasmic maturation, granule formation, and platelet development. The relevant target genes are yet to be identified.
It is unclear whether absence of a more dramatic erythroid phenotype in the absence of NF-E2II5 reflects redundancy at the level of transcription factors, LCR cis-elements, or neither. A number of p45 NF-E2-related factors are known to be widely expressed, as are p18 NF-E2 and its homonot thrombocytopenic."'" Clearly, the potential for combinatorial diversity is vast, and determination of the roles of individual proteins will require a combination of experimental approaches. loguesl 14.1 17-122. , interestingly, mice lacking p18 NF-E2 are
SPECIFICITY WITHIN UBIQUITY: THE CASE OF c-fos
Differentiation is a complex process in which the fate of a given cell depends as much on the signals that it receives as on its unique response to those signals. Although lineagerestricted transcription factors are particularly appealing candidates as key regulators of differentiation, they do not appear to exercise a monopoly in this function. Rather, widely
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From expressed or even ubiquitous transcription factors may occupy a special niche in a limited number of cell types in which they subserve a unique function, presumably through interactions with lineage-restricted proteins. Such is the case with the bHLH protein products of the E2A gene (see below) and with the bZip protein Fos, one component of the AP-1 transcription factor complex.
Mice carrying targeted disruptions of the c-fos gene display osteopetrosis as a primary pathology (similar to mice lacking c -s~c '~~) and altered hematopoiesis as a secondary effect of this. 124~125 In addition, they exhibit delayed gametogenesis and certain behavioral abnormalities that may be unrelated to the primary pathology. Thus, the absence of this widely expressed transcription factor, which has been suggested to mediate many immediate-early responses, results in a narrow spectrum of cellular abnormalities, indicating a restricted range of essential functions. Interestingly, overexpression of c-fos in transgenic mice leads to dysregulated bone growth and development of sarcomas, effects that can be traced to the osteoblast and chondroblast lineages.
Osteopetrosis in c-fos-null mice results from a failure of the appropriate hematopoietic progenitor to differentiate into functional osteoclasts, although the tartrate-resistant acid phosphatase (TRAP)-positive precursor cell is present. ''' The defect is cell-autonomous, ie, intrinsic to the hematopoietic cell precursor, and can be reversed by restoration of c-fos expression within the mutant cells. Macrophage differentiation and function are not impaired; in fact, these cells are present in increased numbers in the bone marrow. Thus, with respect to hematopoiesis, c-fos is required for the differentiation of a specific subset of precursors, presumably by virtue of directing a tissue-specific program of gene expression. The parallels with the related, albeit lineage-restricted, bZip transcription factor p45 NF-E2 are striking. Each plays an essential role in terminal differentiation, but not in lineage commitment, of a specific subset of hematopoietic progenitors.
The ontogenic relationship among monocyte derivatives is poorly understood and it is likely that distinct groups of transcription factors function to specify individual sublineages. A priori, it is impossible to predict whether differentiation of each of these is under the control of lineage-restricted or widely expressed transcription factors or if a subgroup of bZip factors regulates differentiation of all monocyte derivatives. The zinc-finger transcription factor egr-l/Krox24/NGIF-A/Zif268/Tis8 has been shown to restrict differentiation along the macrophage lineage in vitro,12' but mice lacking this product appear to have normal numbers of monocytes. I" Similarly, mice lacking NF-IM/NF-M/C-EBPP, a candidate regulator of macrophage differentiation, do produce monocytes, although these cells show severe functional defects related in part to impaired cytokine production.13'
HOMEOBOXES AND HEMATOPOIESIS: ORGANOGENESIS THROUGH H o x l l
As discussed above, hematopoiesis occurs in defined sites at different stages of development; the disparate differentiation programs are likely influenced profoundly by the microenvironment within which they operate. Therefore, an appreciation of hematopoiesis is incomplete without considering anatomic aspects, including the control of organogenesis. Little is known about the genetic basis of yolk sac or bone marrow formation; however, the finding that formation of the spleen is regulated by a homeobox genet3' has provided an important link between the cellular and morphogenic aspects of hematopoiesis.
Like tal-1/SCL and rbtn2LM02, Hoxl UTCL-3 was originally identified through a chromosomal translocation found in human T-cell ALL.'" In mice, it is expressed in discrete segments of developing branchial arches and the hindbrain and in the splanchnic mesoderm."' Mice lacking Hoxl 1 are asplenic, which results in leukocytosis, but the body plan, other aspects of organogenesis, and extrasplenic hematopoiesis are not obviously affected. Rather, the absence of Hoxl 1 leads to a specific defect in mesodermal cells normally destined to form the spleen. Recent evidence indicates that these cells do initiate spleen formation but then rapidly undergo apoptosis, implicating Hox 11 in cell survival rather than lineage specification."' It is possible that other transcription factors similarly direct formation of the yolk sac, fetal liver, and bone marrow.
Hox 1 l/TCL-3 is not the only homeobox gene to be implicated in an aspect of hematopoiesis. Expression of several clustered HOX genes has been noted in human hematopoietic cell lines,'34 with some variation in the pattern among myeloid versus erythroid lines and a proposed role in control of cell proliferati~n."~~"~ Expression of the clustered genes HOXB3 and HOXB4 is greatest in CD34' progenitors and declines with overexpression of HOXB4 in murine bone marrow cells results in increased proliferation of hematopoietic (stem) cells capable of myelolymphoid reconstitution,'" whereas inhibition of expression in vitro appears to compromise the proliferative capacity.'" It remains to be determined whether the products of these or other clustered homeobox genes play an essential role in the differentiation of hematopoietic progenitors in vivo. Thus far, disruption of many clustered homeobox genes has not resulted in obvious hematopoietic defects."' However, mild anemia and thrombocytopenia without morphologic abnormalities have been reported in mice heterozygous for the mixed-lineage leukemia (MLL/ALL-1) gene; homozygosity is lethal for other reason^.'^' MLUALL-1, a positive regulator of Hox gene expression, is also a target of dysregulation in human leukemias.
VARIATIONS ON A THEME: TRANSCRIPTION FACTORS AND LYMPHOID DEVELOPMENT
As in other hematopoietic lineages, transcription factors belonging to diverse protein families play pivotal roles in development of the lymphoid system. The principles of differentiation emerging from these studies are fundamentally similar to those reviewed above; four illustrative examples are discussed here.
The zinc-finger transcription factors encoded by the Ikaros gene were originally identified on the basis of their ability to active the enhancer of the T-cell marker gene CD3S. Ikaros is expressed exclusively within lymphocytes and early hematopoietic progenitor^,'^' wherein it is believed to regulate the expression of a number of lineage-specific genes. Mice lacking Ikaros function display a complete ab-
Ikaros.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From sence of mature T and B lymphocytes and natural killer (NK) cells and of most lymphoid progenitors and die of infe~ti0n.l~' In addition, these mice exhibit splenomegaly and alterations in the ratio of myeloid to erythroid cells, which are difficult to explain but could potentially reflect a role for the factor within multipotential hematopoietic progenitors. The occasional detection of putative lymphoid prec u r s o r~~~~ suggests an essential role for Ikaros in the progression of differentiation rather than in lymphoid cell commitment. Remarkably, mice with a mutation in a single copy of the Ikaros gene (heterozygotes) develop a lethal lymphoproliferative disease.'43 These results implicate Ikaros as a pivotal mediator of cell differentiation operating at the earliest stages of maturation of all lymphoid lineages, including NK cells; recognition of a number of putative target genes that are expressed at all stages further suggests a continued role in later or antigen-dependent maturation. Within the lymphoid system, therefore, Ikaros function is perhaps most analogous to that of tal-1/SCL or GATA-1 in other aspects of hematopoiesis.
The E12 and E47 protein products of the E2A gene, identified through cDNA cloning of factors binding to an Ig K enhancer element," are bHLH transcription factors expressed in all mammalian tissues. These proteins form homodimers and heterodimers with a wide variety of related proteins in various tissues, including tal-l/SCL in hematopoietic cells and myogenic bHLH factors in muscle tissue; sequence specificity for DNA binding is determined by the particular omb bin at ion.''.^^ In vitro studies had thus suggested that the E2A factors regulate cell growth and differentiation in many cell types. Although mice lacking the E2A gene are retarded in growth and die perinatally for unknown reasons, careful analysis has thus far shown an essential role for its products only in B cells.'"-'46 Mature B cells are absent, whereas there are no significant abnormalities of other hematopoietic and nonhematopoietic lineages, including T lymphocytes. As with many examples cited above, it is extremely difficult to pinpoint the developmental stage at which B lymphopoiesis is arrested; the presence of rare B220 (CD45)' cells might suggest that the defect lies beyond the step of lineage commitment, yet among the earliest stages of B-cell maturation. Inasmuch as this phenotype shows a highly restricted essential function for a widely expressed factor, it is reminiscent of the differentiation arrest in mice lacking c-fos.
A founding member of the POU subfamily of homeobox transcription factors, Oct-2 is expressed principally in B lymphocytes, in which it binds to the octamer motif present in all Ig promoters and most enhancer^.'^' Mice lacking Oct-2 develop normally but die shortly after birth of unknown causes.148 Early B-cell development, including rearrangement and transcription of Ig genes and the number of pre-B cells, is normal. Although the number of mature B cells in neonates is only slightly reduced, there is a dramatic reduction in the frequency of cells capable of responding to mitogens in vitro and secreting antibodies and in the amount of Ig secreted per cell. The analysis of the Oct-2-null phenotype was performed in newborn mice, in which B-cell subsets may be substantially different from adults. Interpretation of the findings is further complicated by the presence of E2A.
Oct-2.
potentially separate effects on gene (Ig) expression and differentiation and the unexplained death of the mutant animals. Nevertheless, it is clear that Oct-2 is dispensable for early Bcell development but required for optimal antigedmitogendependent maturation in vitro into Ig-secreting cells. Thus far, the only target gene whose expression in B lymphocytes is critically dependent on Oct-2 encodes the cell surface glycoprotein CD36,'49 whose specific role in late B-cell maturation remains unclear.
The octamer-binding proteins Oct-1 and Oct-2 provide an instructive example of how lineage specificity of gene expression may be achieved. Their identical DNA-binding specificity and in vitro activity raise the possibility that the ubiquitously expressed factor Oct-1 can function in place of Oct-2 when the latter is absent. Oct-1 activates B-cell-specific gene expression by forming a ternary complex on DNA with the B-cell-specific coactivator OBF-1, which does not exhibit independent transcription factor function^.^^^-'^^ High-level expression of Ig genes in B cells requires the recruitment of OBF-1 to the promoter by DNA-bound Oct-1,Oct-2, or both. Such coactivators, or adaptors, are believed to function by facilitating interactions between transcriptional activators and the basal transcription ma~hinery"~ and may underlie cell-specific gene expression in many instances.
Activation of gene expression involves the formation of a nucleic acid-protein complex that permits or facilitates RNA transcription. Among the DNAbinding proteins that participate in these complexes are the architectural transcription factors, which bend DNA and serve to bring DNA-bound proteins in app~sition."~ The high-mobility group (HMG) family of nuclear proteins includes the closely related architectural transcription factors LEF-1 and TCF-1, whose expression is widespread during embryogenesis but largely restricted to T and B lymphocytes p~stnatally.'~~ Mice lacking TCF-1 function display thymic hypoplasia with cortical hypocellularity, 10-to 100-fold reduction in the total number of thymocytes, and threefold to 10-fold reduction in the numbers of splenic and lymph node T cells.156 Numbers of B and NK cells, rearrangement of the T-cell receptor p chain gene, the T-cell response to mitogens, and overall health and viability are unaffected. These findings, which reflect a unique differentiation block occumng at the transition between immature CD8+ precursors and the more mature CD4+CD8+ T lymphocyte subpopulation, provide the only example to date in which absence of a transcription factor exclusively affects the T-cell lineage. In contrast, mice lacking LEF-1 die as a result of a number of abnormalities in organogenesis but appear to have an intact lymphoid compartment,"' possibly compensated by TCF-1.
Gene disruption experiments have established a crucial role for transcription factors in many aspects of lymphopoiesis, ranging from putative lineage specification to the regulation of antigen-driven maturation, as illustrated above and summarized in Table 1 . Thus, lineage-restricted transcription factors appear to function in principally similar ways in many aspects of hematopoiesis. Furthermore, parallels between the transcriptional control of cell differentiation in other tissues and in hematopoie~is'~~.'~~ underscore the essential conservation of molecular mechanisms underlying development of disparate organs and cell types.
TCF-1 and LEF-1.
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CONCLUSIONS AND FUTURE DIRECTIONS
As shown in Fig 5, key transcription factors regulate multiple aspects of hematopoietic differentiation-from lineage commitment through terminal maturation. As outlined, this scheme reflects the premise that differentiation is fundamentally a process of ordered gene regulation that culminates in the expression of a unique complement of specific and widely expressed genes in each cell type. Even in the absence of reliable experimental methods for identification of the relevant target genes of a given transcription factor, study of critical lineage-specific factors has provided an invaluable window into the molecular basis of cell differentiation.
Although based on the results reviewed above, the scheme depicted in Fig 5 may be deceptively simple. Because knockout phenotypes show only the earliest block in a pathway, the true hierarchy among regulatory factors is in fact speculative, and it is likely that multiple interactions among the listed proteins and among other lineage-restricted or ubiquitous factors occur throughout the developmental cascade. Indeed, the genetic program of a cell must be determined by combinations of transcription factors rather than by single proteins.
The phenotypic analysis of knockout mice is usually a simple study at the level of organs and cells. As such, fundamental questions related to the mechanisms by which loss of critical target genes interferes with cell differentiation remain largely unanswered. The most important outcome of the knockout experiments reviewed above has been the establishment of candidate proteins as essential regulators of differentiation. Gene knockouts have thus set the stage for future identification of crucial target genes and for the study of how transcriptional regulation of individual genes impacts on cell differentiation.
The factors discussed here were originally identified either through recurring chromosomal translocation in human leukemia or on the basis of their binding to critical cis-regulatory elements of lineage-specific genes. These are likely to remain important sources for characterization of novel transcription factors that regulate development.
Genes encoding proteins other than transcription factors are also required for various aspects of cell differentiation. Within hematopoietic cells, an essential role has been shown for several signal transduction molecules, including the growth factors G-CSF;' GM-CSF,I5' thrombopoietin,'6n and erythropoietin," the receptor tyrosine kinase Flk-1 , I h ' and the Janus kinase Jak3.'62,'63 Hematopoietic defects have been noted in diverse knockout models, including the Retinoblastoma,'".''' C-myc,'" platelet-derived growth factor,'" and RelB "' genes. Indeed, transcription factor function is modulated by numerous influences, including signals delivered by cytokines and growth factors, cell-cell interactions, and the stage of the cell cycle. Although the impact of some of these influences on transcriptional regulators is known, their effect on lineage-specific factors has largely been unexplored and promises to be a fruitful area of study in the future. How the expression of key transcription factors is initiated in progenitor cells is unclear. Possibilities include a "stochastic" (unregulated) process or a finely tuned response to external signals. Study of the regulation of some key transcription factors will allow investigators to begin addressing this question. Finally, selection between alternate lineages likely involves both activation and silencing of dia- 
